Albany Molecular Research Income Statement
View: Annual | Quarterly
This data is provided as per license from EDGAR Online
| Dec 07 | Dec 06 | Dec 05 | |
|---|---|---|---|
| Revenue | 192.5 | 179.8 | 183.9 |
| Cost of Goods Sold | 132.0 | 128.6 | 114.7 |
| Gross Profit | 60.5 | 51.2 | 69.2 |
| Gross Profit Margin | 31.4% | 28.5% | 37.6% |
| SG&A Expense | 32.1 | 36.5 | 30.1 |
| Depreciation & Amortization | 17.0 | 15.5 | 15.5 |
| Operating Income | 11.4 | (0.9) | 23.5 |
| Operating Margin | 5.9% | -- | 12.8% |
| Nonoperating Income | 3.9 | 4.2 | 3.4 |
| Nonoperating Expenses | 0.9 | 1.1 | 1.8 |
| Income Before Taxes | 14.4 | 2.2 | 25.1 |
| Income Taxes | 5.4 | 0.1 | 8.8 |
| Net Income After Taxes | 8.9 | 2.2 | 16.3 |
| Continuing Operations | 8.9 | 2.2 | 16.3 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | 8.9 | 2.2 | 16.3 |
| Total Net Income | 8.9 | 2.2 | 16.3 |
| Net Profit Margin | 4.6% | 1.2% | 8.9% |
| Diluted EPS from Total Net Income ($) | 0.27 | 0.07 | 0.50 |
| Dividends per Share | -- | -- | -- |
This data is provided as per license from EDGAR Online
